Overview
DSIP is a nonapeptide with the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, first described in 1977.
Research context
DSIP is studied in preclinical neuroscience research, including models of sleep architecture, stress response and neuroendocrine signalling. Its receptor and mechanism of action are still under investigation.
Specifications
- Form: Lyophilized powder
- Quantity: 10 mg
- Container: 3 mL glass vial, sealed
- Storage: Minus 20 °C, dry and protected from light
- Documentation: Lot-specific Certificate of Analysis (identity and purity by HPLC-MS), matched to the batch number on the label
For laboratory research use only. Not a drug, food, cosmetic or medical device. Not for human or animal use of any kind. No usage guidance is provided.



